Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

RMMI Corp. Announces Filing of Its Financial Statements and Related Management Discussion and Analysis for Q2 2018


Posted on: 23 Aug 18

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.

CALGARY, Alberta, Aug. 23, 2018 (GLOBE NEWSWIRE) -- RMMI Corp. (“RMMI”) announced today that it has filed its financial statements and related management discussion and analysis for the three and six month periods ended June 30, 2018 under its profile on the SEDAR filing system (www.sedar.com).

About RMMI Corp.

RMMI is an Alberta based company that will focus on the production, cultivation and sale of medical marijuana in various forms, including dried marijuana and cannabis oil. RMMI, through its wholly-owned subsidiary, Rocky Mountain Marijuana Inc., has applied for a Licence to Produce under the Access to Cannabis for Medical Purposes Regulations (Canada).  RMMI is currently at a development stage and has yet to obtain the requisite licence to commence operations.

For more information about RMMI, please visit https://www.rmmi.ca.

For more information, please contact:

RMMI Corp.
#1050 – 639-5th Avenue S.W.
Calgary, AB T2P 0M9   

Earl Connors, President and Chief Executive Officer     
403-984-6446    
ec@rmmi.ca

GlobeNewswire
globenewswire.com

Last updated on: 24/08/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.